Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Recruiting Not applicable

Ultrasonic Versus Conventional Clipping Hemostasis in Laparoscopic Colorectal Surgery

NCT07129512 · tracked via the Priya Life Science South Korea tracker
Phase
Not applicable
Started
2024-03-04
Last updated
2025-08-19

Condition(s) studied

Adenocarcinoma of the Colon

Investigational drug(s) / intervention(s)

Intracorporeal anastomosisExtracorporeal anastomosis

Intracorporeal anastomosis: In this group, the vessel ligation and dissection is performed using an ultrasonic scalpel with advanced hemostasis mode.

Extracorporeal anastomosis: In this group, the vessel ligation and dissection is performed using a monopolar energy device and surgical clips.

Study summary

INTRODUCTION Colorectal cancer rates are rising, with surgery emphasizing radical resection and vessel ligation. Conventional methods using clips pose risks of bleeding and complications. Ultrasonic scalpels offer a safer alternative, approved for various surgeries, but their efficacy in colorectal cancer surgery needs prospective validation.

STUDY OBJECTIVE Study compares safety/efficacy of clipless vs. clip-type hemostasis using ultrasonic scalpel in colorectal surgery, focusing on post-op bleeding frequency, intraoperative bleed, drainage, hospital stay.

STUDY DESIGN This study is a prospective, randomized, single-center study comparing clipless ultrasonic energy-based hemostasis versus conventional clipping hemostasis in performing laparoscopic colectomy. The study's experimental group undergoes surgery with an ultrasonic scalpel, while the control group receives treatment with a monopolar energy device and clips. Allocation to groups, using a 1:1 ratio, is randomized via a computerized table by a blinded coordinator, immediately post-anesthesia. Principal investigators and administrators remain blinded throughout the study.

STUDY POPULATION

1\. Screening A detailed review of the medical records will be performed to assess inclusion/exclusion criteria for all subjects who have been diagnosed with colonic adenocarcinoma and are subject to a colectomy procedure.

All patients who are eligible, meet the inclusion and none of the exclusion criteria of this study, will be offered enrollment into the study at each site.

RISK ANALYSIS The surgical procedure, postoperative care, and follow-up will be the same for the experitmental and control groups in this study. The use of the ultrasonic scalpel alone may prevent complications such as clip-induced intestinal obstruction, infection, bleeding from clip dislodgement, bile leakage, and infection, but there is no additional benefit for other subjects. The risk of bleeding when ligating vessels with an ultrasonic scalpel has been demonstrated to be safe in retrospective studies for vessels 7 mm or less (8-17). Vessels larger than 7 mm are ligated using surgical clips because the safety of ligation with the ultrasound scalpel has not been studied. Based on the reported safety of this method of ligation, the risks do not outweigh the benefits when analyzed in the aggregate.

QUALIFICATION OF PARTICIPATING SURGEONS

1. Surgical procedure

* Laparoscopic surgery: Surgery for colorectal cancer consists of ligating blood vessels to the lesion, detaching or mobilizing the colon, and resecting and anastomosing the bowel.
* Clipless ultrasound energy-based hemostasis arm: the ultrasound scalpel is used to dissect and ligate the vessel, but clips are used for vessels larger than 7 mm in diameter. If there is significant bleeding during the procedure, surgical clips and hemostatic agents may be used for patient safety at the discretion of the surgeon.
* Control arm: a combination of monopolar cautery and surgical clips will be used for vascular ligation and lymph node dissection.
2. Procedure standardization and qualification procedure This study is about laparoscopic surgery for colorectal cancer and all surgeries will be performed by surgeons with at least 100 laparoscopic colorectal cancer surgeries.

STATISTICAL ANALYSIS This study compares the frequency of postoperative bleeding between clipless and clip-type ultrasound energy hemostasis in laparoscopic colorectal cancer surgery, assuming that there will be deviations from randomization, such as switching of surgical groups after randomization or additional vessel ligation with clips during or after surgery, we will perform a per-protocol analysis.

The missing values of postoperative bleeding, intraoperative blood loss, intraoperative blood transfusion, and conversion to laparotomy are assumed to be none, and the missing values of postoperative drainage tube hematocrit and drainage tube triglycerides are converted to the mean values of the same group. Outliers will be retained without replacement for intraoperative blood loss, operative time, maximum postoperative plasma hemoglobin decline, and total drainage volume within 5 days postoperatively.

For Type 1 errors, the frequency of postoperative intra-abdominal bleeding in the control group will be analyzed during data safety monitoring every 50 cases to ensure that it is less than 0.5-4.5% according to the literature.

Eligibility

Sex
ALL
Min age
19 Years
Max age
80 Years
Healthy volunteers
No
Inclusion Criteria: * Adults 19 to 80 years of age * Patients with histologically confirmed pathologic adenocarcinoma of the colon * Patients with an ECOG score between 0 and 2 * Patients with a preoperative ASA score of I to III * Patients without a history of surgery for abdominal malignancies * Patients with no history of anticoagulation prior to surgery * Patients who understand the study process and treatment plan and are able to complete the informed consent form themselves Exclusion Criteria: * Patients with an ASA score of 4 or higher * People with blood clotting disorders such as liver cirrhosis, end-stage renal failure, or hematologic disorders * Pregnant women * Mentally ill patients who have difficulty giving informed consent * Preoperative blood hemoglobin (Hb) less than 7 g/dL * Patients taking anticoagulants before or after surgery * Patients who have undergone emergency surgery * Patients who are unable to be followed up on an outpatient basi * No Informed consent

Primary outcome measure(s)

  • Frequency of postoperative intra-abdominal bleeding with Clavien-Dindo grade II or higher — within 30 postoperative days
    Evaluation of the presence of intra-abdominal bleeding after surgery for Clavien-Dindo grade II or greater is considered positive if any of the following are satisfied within postoperative 30 days 1. Blood transfusion was performed because of suspected intra-abdominal bleeding. 2. A contrast-enhanced abdominal pelvic tomogram performed for suspected intra-abdominal hemorrhage demonstrates contrast leakage or the presence of a hemoperitoneum. 3. Angiographic thromboembolization for intra-abdominal bleeding. 4. Reoperation for intra-abdominal bleeding.

Trial sites (1)

FacilityCityRegionStatus
Division of Colon and Rectal Surgery, Department of Surgery, Yonsei University College of Medicine Seoul South Korea Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07129512 on ClinicalTrials.gov ↗ ← All trials in South Korea